A NOVEL RP-HPLC METHOD FOR THE DETECTION AND QUANTIFICATION OF CLARITHROMYCIN OR SPIRAMYCIN IN BULK DRUG SAMPLES AND DOSAGE FORMS
Objective: This study was aimed at developing an HPLC method that would be suitable and sufficiently robust to analyze clarithromycin or spiramycin from bulk materials, amorphous solid dispersions as well as when included into solid dosage forms.
Methods: A C8 column (250 x 4.6 mm, 5Â Âµm) was used as stationary phase, the mobile phase consisted of 0.1Â M dipotassium hydrogen orthophosphate buffer (pH 6.0) and acetonitrile in a 50:50 (%Â v/v) ratio. The flow rate was set to 0.5Â ml/min. UV detection of 210 nm was used for clarithromycin and 232 nm for spiramycin. Ambient column and sample tray temperatures were used.
Results: The method proved to be suitable for the detection of both macrolide antibiotics in bulk samples, as part of amorphous solid dispersions as well as in dosage forms. The isocratic elution was rapid. The method was validated in terms of system suitability, limits of detection (LOD), limit of quantification (LOQ), accuracy, precision, linearity, and specificity. This method showed linearity across the concentration range of 4.0â€“5000.0 Âµg/ml for both antibiotics.
Conclusion: The developed method showed to be a simple and sufficiently sensitive method for the detection and quantification of either clarithromycin or spiramycin from samples that might contain even very small quantities of the antibiotics.
2. Rubaihayo J, Tumwesigye NM, Konde-Lule J. Trends in the prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda. BMC Infect Dis 2015;15:1.
3. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:1098-107.
4. Davis S. Macrolides and ketolides: more than just antimicrobials. Southeast Asia Psychol J 2011;78:24-7.
5. Sprinz E, Mallman R, Barcellos S, Silbert S, Schestatsky G, Bem David D. AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin. J Antimicrob Chemother 1998;41 Suppl B:85-91.
6. Huang MZ, Li J, Guan L, Li DQ, Nie XM, Gui R, Chen X. Therapeutic effects of acetyl spiramycin and garlicin on cryptosporidiosis among drug users. Int J Parasitol: Drugs Drug Resist 2015;5:185-90.
7. Wang D, Zhang YY. Intestinal pathological changes of Kunming mice infected by Cryptosporidium and the therapeutic efficacy of spiramycin on infected mice. Zhongguoji sheng chongxueyuji sheng chongbingzazhi. Chin J Parasitol Parasitic Diseases 2014;32:225-8.
8. British Pharmacopoeia. The Department of Health. Vol. VI. London: The Stationery office; 2016.
9. United States Pharmacopoeia-39. National Formulary-34; Pharmacopeial forum; 2016. p. 8027.
10. Li W, Jia H, Zhao K. Determination of clarithromycin in rat plasma by HPLC-UV method with pre-column derivatization. Talanta 2007;71:385â€“90.
11. Maher HM, Youssef RM, Khalil RH, El-Bahr SM. Simultaneous multi-residue determination of metronidazole and spiramycin in fish muscle using high-performance liquid chromatography with UV detection. J Chromatogr B 2008;876:175â€“81.
12. Oka H, Harada KI, Suzuki M, Ito Y. Separation of spiramycin components using high-speed counter-current chromatography. J Chromatogr A 2000;903:93â€“8.
13. Wang MJ, Pendela M, Hu CQ, Jin SH, Hoogmartens J, Van Schepdael A, et al. Impurity profiling of acetyl spiramycin by liquid chromatography-ion trap mass spectrometry. J Chromatogr A 2010;1217:6531â€“44.
14. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. [Last accessed on 25 Aug 2016].